Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
Open in App
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Biocon Ltd.
NSE: BIOCON
|
BSE: 532523
|
ISIN: INE376G01013
|
Industry: Biotechnology
Regulatory Approval
|
Mid-range Performer
416.0000
-2.40
(
-0.57
%)
NSE
Aug 28, 2026
10:39 AM
Volume:
332.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Biocon Ltd.
20 Nov 2024
Regulatory Approval
416.00
-0.57%
BIOCON LTD
Accumulate:
Biocon Ltd.
by
Geojit BNP Paribas
Target: 376
Target
Geojit BNP Paribas
Biocon Ltd. has an
average target
of 412.80 from 5 brokers.
More from Biocon Ltd.
Recommended
Market trades higher, Tejas Networks secures a Rs 1,537 crore order from TCS
Trendlyne Marketwatch |
28 Aug 2026, 10:22AM
From weak rains to rural spending: India’s next monsoon test
The Baseline |
27 Aug 2026, 06:43PM
A long drawn out R&D plan may be finally paying off for Biocon
|
20 Aug 2020